Your browser doesn't support javascript.
loading
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors.
Leaf, Rebecca Karp; Ferreri, Christopher; Rangachari, Deepa; Mier, James; Witteles, Wesley; Ansstas, George; Anagnostou, Theodora; Zubiri, Leyre; Piotrowska, Zofia; Oo, Thein H; Iberri, David; Yarchoan, Mark; Salama, April K S; Johnson, Douglas B; Leavitt, Andrew D; Rahma, Osama E; Reynolds, Kerry L; Leaf, David E.
Afiliação
  • Leaf RK; Division of Hematology, Massachusetts General Hospital, Boston, Massachusetts.
  • Ferreri C; Department of Internal Medicine, Duke University Hospital, Durham, North Carolina.
  • Rangachari D; Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Mier J; Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Witteles W; Divison of Hematology and Oncology, VA Palo Alto Health Care System, Palo Alto, California.
  • Ansstas G; Division of Hematology and Oncology, Washington University St. Louis, St. Louis, Missouri.
  • Anagnostou T; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
  • Zubiri L; Division of Hematology, Massachusetts General Hospital, Boston, Massachusetts.
  • Piotrowska Z; Division of Hematology, Massachusetts General Hospital, Boston, Massachusetts.
  • Oo TH; Section of Benign Hematology, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
  • Iberri D; Division of Hematology, Stanford University Medical Center, Stanford, California.
  • Yarchoan M; Division of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Salama AKS; Division of Medical Oncology, Duke University Hospital, Durham, North Carolina.
  • Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Leavitt AD; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Rahma OE; Division of Medical Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts.
  • Reynolds KL; Division of Hematology, Massachusetts General Hospital, Boston, Massachusetts.
  • Leaf DE; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Am J Hematol ; 94(5): 563-574, 2019 05.
Article em En | MEDLINE | ID: mdl-30790338
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Hemoglobinas / Terapia de Imunossupressão / Anemia Hemolítica Autoimune Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Hemoglobinas / Terapia de Imunossupressão / Anemia Hemolítica Autoimune Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article